Business Description
Allergy Therapeutics PLC
ISIN : GB00B02LCQ05
Compare
Compare
Traded in other countries / regions
AGY.UKHHU.GermanyAGYTF.USA IPO Date
2020-08-03Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.06 | |||||
| Debt-to-Equity | 8.36 | |||||
| Debt-to-EBITDA | -1.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.09 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.7 | |||||
| 3-Year Book Growth Rate | -76.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.83 | |||||
| 9-Day RSI | 65.5 | |||||
| 14-Day RSI | 61.34 | |||||
| 6-1 Month Momentum % | -2.5 | |||||
| 12-1 Month Momentum % | 207.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.63 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 173.12 | |||||
| Days Sales Outstanding | 33.42 | |||||
| Days Payable | 134.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -94.1 | |||||
| Shareholder Yield % | 0.01 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.87 | |||||
| Operating Margin % | -61.63 | |||||
| Net Margin % | -72.86 | |||||
| FCF Margin % | -64.68 | |||||
| ROE % | -374.25 | |||||
| ROA % | -60.12 | |||||
| ROIC % | -83.39 | |||||
| ROC (Joel Greenblatt) % | -149.45 | |||||
| ROCE % | -77.17 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.54 | |||||
| PB Ratio | 60.16 | |||||
| EV-to-EBIT | -9.17 | |||||
| EV-to-Forward-EBIT | -13.79 | |||||
| EV-to-EBITDA | -10.46 | |||||
| EV-to-Forward-EBITDA | -18 | |||||
| EV-to-Revenue | 5.81 | |||||
| EV-to-Forward-Revenue | 4.92 | |||||
| EV-to-FCF | -8.83 | |||||
| Price-to-Median-PS-Value | 2.25 | |||||
| Earnings Yield (Greenblatt) % | -10.92 | |||||
| FCF Yield % | -11.74 | |||||
| Forward Rate of Return (Yacktman) % | -4.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Allergy Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 64.531 | ||
| EPS (TTM) (€) | -0.013 | ||
| Beta | 8.96 | ||
| Volatility % | 83.8 | ||
| 14-Day RSI | 61.34 | ||
| 14-Day ATR (€) | 0.004717 | ||
| 20-Day SMA (€) | 0.061125 | ||
| 12-1 Month Momentum % | 207.89 | ||
| 52-Week Range (€) | 0.0175 - 0.074 | ||
| Shares Outstanding (Mil) | 4,766.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allergy Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allergy Therapeutics PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allergy Therapeutics PLC Frequently Asked Questions
What is Allergy Therapeutics PLC(FRA:HHU)'s stock price today?
The current price of FRA:HHU is €0.07. The 52 week high of FRA:HHU is €0.07 and 52 week low is €0.02.
When is next earnings date of Allergy Therapeutics PLC(FRA:HHU)?
The next earnings date of Allergy Therapeutics PLC(FRA:HHU) is 2025-03-27 Est..
Does Allergy Therapeutics PLC(FRA:HHU) pay dividends? If so, how much?
Allergy Therapeutics PLC(FRA:HHU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers